Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) FCF Margin (2016 - 2025)

CorMedix has reported FCF Margin over the past 10 years, most recently at 72.11% for Q4 2025.

  • Quarterly results put FCF Margin at 72.11% for Q4 2025, up 9013.0% from a year ago — trailing twelve months through Dec 2025 was 55.43% (up 17205.0% YoY), and the annual figure for FY2025 was 55.43%, up 17213.0%.
  • FCF Margin reached 72.11% in Q4 2025 per CRMD's latest filing, up from 29.11% in the prior quarter.
  • Across five years, FCF Margin topped out at 75.42% in Q2 2025 and bottomed at 89069.3% in Q3 2022.
  • Median FCF Margin over the past 4 years was 7595.53% (2021), compared with a mean of 19961.88%.
  • Peak annual rise in FCF Margin hit 1206455bps in 2022, while the deepest fall reached -8078407bps in 2022.
  • Over 4 years, FCF Margin stood at 11522.1% in 2021, then crashed by -84bps to 21155.46% in 2022, then soared by 100bps to 18.02% in 2024, then soared by 500bps to 72.11% in 2025.
  • Business Quant data shows FCF Margin for CRMD at 72.11% in Q4 2025, 29.11% in Q3 2025, and 75.42% in Q2 2025.